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Abstract
Background: Obesity has been demonstrated to be associated with increased serum uric acid (SUA); however, little is
known regarding the relationship between maximum weight, or maximum weight fluctuation, and uric acid concentration.
Through retrospective means, we determined the association of maximum weight with SUA risk.
Methods: Data of 21,414 participants (8,630 males and 12,784 females) from the 2007-8 China National Diabetes and
Metabolic Disorders Study were analyzed for parameters including lifestyle habits, biochemical blood analysis and selfreported maximum weight.
Results: Elevated SUA subjects shared a cluster of demographic features. After adjustment for age, gender, education,
smoking, drinking, physical activity, WHR, height, eGFR(evaluate glomerular filtration rate), and diuretic usage, multivariate
logistic regression models demonstrated maximum weight was associated with increased risk of elevated SUA level
(P,0.001). Duration of maximum weight was related with decreased risk of elevated SUA level (P,0.001). There was a
significant correlation between time of weight loss and risk of increased SUA level reduction (P,0.001). Furthermore, our
data indicated that the degree of weight loss from maximum weight was another important factor for the risk of increased
SUA level reduction (P,0.001). Finally, ROC curve analysis revealed area under the curve was 0.661 (95% CI, 0.647-0.674),
statistically significant for maximum weight association with hyperuricemia (P,0.001).
Conclusions: Maximum weight is a strong risk factor for increased uric acid level in the Chinese population, which might
serve as a novel clinical indicator suggesting hyperuricemia. Controlling maximum weight, keeping weight to the
appropriate range, and maintaining the stable weight may be conducive for decreasing risk of hyperuricemia.
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a predictor for SUA change [8]. As the association between obesity
and SUA is well established, weight is an important modifiable risk
factor for hyperuricemia [8,9].
Weight loss is not a simple, nor uniform, matter in different
persons. Despite efforts, many obese individuals have difficulty
altering their overweight status, and many enter a cyclical pattern
of weight loss with re-gain [10]. Continued aerobic exercise post
weight re-gain may counter the detrimental effects of partial
weight re-gain, as evidenced by several metabolic markers [11].
Weight fluctuations in the obese condition are therefore closely
associated with metabolic disorders. Several large populationbased epidemiologic studies of diabetes mellitus have investigated
maximum weight, reflective of the maximum obesity state [12,13].
However, data remains limited on the association between
maximum weight and SUA, or regarding weight change from

Introduction
Worldwide prevalence of hyperuricemia is increasing rapidly.
Data from a large managed care database in the USA indicates
that the annual prevalence of gout and/or clinically significant
hyperuricemia increased from 2.9 per thousand in 1990 to 5.2 per
thousand in 1999[1]. In the coastal city Tianjin of China,
hyperuricemic prevalence was 12.16%, with male significantly
higher than female in 2011[2]. Increasing evidence supports a
relationship between hyperuricemia and metabolic syndrome risk
factors including hypertension, hyperlipidemia, diabetes, obesity,
and insulin resistance [3,4,5,6]. Also, many studies have focused
on the association between serum uric acid (SUA) and weight.
After age adjustment, gout patients have significantly greater body
mass index (BMI) in the Framingham Study [7]. After 2-year
follow up of 3,153 individuals, Ishizaka reported BMI change was
PLOS ONE | www.plosone.org
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males) or 6.0 mg/dl (357 mmol/l, female) as previously defined
[16,17].
After physical examination, participants were subject to
collected fasting venous blood specimen. Fasting serum was
utilized to determine uric acid and other serum biochemical
parameters. All biochemical testing had successfully completed at
a standardization/certification program.

the maximum obesity condition. The 2007–8 China National
Diabetes and Metabolic Disorders Study is the most current
national cross-sectional survey in China [14]. Drawing from the
survey database, we analyzed the association of the risk of high
SUA level with maximum weight, weight stability, time of weight
loss and the degree of weight loss from the maximum weight. This
study maybe have potential clinical application of assessing
hyperuricemia risk in the obese population.

Statistical Analysis
Methods

EpiData (EpiData Association, Odense, Denmark) established
the database, and SPSS16.0 for Windows (SPSS Inc, Chicago, IL,
USA) was utilized for statistical analyses. After statistical analysis,
all variables were normal distribution and presented either as
mean for continuous variables or proportions for categorical
variables. Comparisons among groups were tested by one-way
ANOVA. The chi-squared test was employed to estimate the
difference for categorical variables. Partial correlation analysis
determined the relationship between SUA and related variables.
Multivariate logistic regression models examined the association
between maximum weight and concentrations of SUA, after
adjusting for age, sex, height, smoking, drinking, education,
physical activity, WHR, eGFR (eGFR = 1866 Scr (mg/dl)21.1546
age (years)20.203(60.742, if female)) [18], and diuretic use. All
statistical tests were two-tailed with type I error set at 0.05, and P
values ,0.05 considered statistically significant.

Study population
All data analyzed in the present study originated from the 2007–
8 China National Diabetes and Metabolic Disorders Study, a
cross-sectional study that obtained data from June 2007 to May
2008 via a multi-stage, stratified sampling design. Details
regarding its sampling methods were based upon our group’s
previous study [14]. SUA was not a requisite test item in each
region in our previous study, so 35 cities and 19 countries
evaluated SUA. A total of 22,020 people (9,120 males and 12,900
females) were included into our database analysis. Additionally,
376 subjects were excluded from the study due to incomplete
information regarding self-reported maximum weight, and 230
subjects were excluded due to missing SUA data. Ultimately,
21,414 subjects were analyzed in the present study. In addition, 50
subjects lacked the information of smoking and drinking. So these
people had not included in the analysis of Table 1. All subjects had
been in our previous study signed an informed consent.

Results
21,414 participants (8,630 males and 12,784 females) were
included in our final analysis (Table 1). Subjects of the highest
SUA quartile shared a cluster of demographic features. Based on
our data, male showed higher SUA concentration and their
likelihood of smoking and consuming alcohol increased dramatically. Table 1 listed the weight related variable characteristics of
the different SUA quartiles. Current weight, BMI, waist circumference and WHR were associated with increased SUA (P,0.001).
Both self-reported maximum weight and BMI increased with
elevated SUA. Age at maximum weight was increased with
elevated SUA (P,0.001). Discrepancy between current and
maximum weight was diminished with elevated SUA level. Ageand gender-adjusted partial correlation analysis demonstrated a
statistically positive correlation between uric acid level and
maximum weight, maximum BMI, and age at maximum weight,
correlation coefficient were 0.194, 0.177, and 0.104, respectively.
After adjustment for the confounding variable of age, gender,
education, smoking, drinking, physical activity, WHR, height,
eGFR and diuretic usage, maximum weight was associated with
increased risk of elevated SUA level (Table 2). When maximum
weight exceeded 70 kilograms, multiple logistic regression models
revealed the odds ratio (OR) of concomitant elevated SUA level
was 1.275, 2.233, and 3.513 in the second, third, and fourth SUA
quartile respectively compared to the lowest SUA quartile. After
adjustment for the same confounding variables, the duration of
maximum weight was associated with reduced risk of elevated
SUA levels (Table 3). For duration of maximum weight extending
beyond 3 years, compared to the lowest SUA quartile, the OR in
the second, third, fourth quartile was 0.619, 0.498, and 0.410,
respectively. Analysis of the interval time between maximum and
current weight (essentially time of weight loss took place)
demonstrated the longer time interval with the lower risk of uric
acid elevation (Table 4), particularly when the time interval
exceeded 10 years (OR for 0–5 year duration, 5–10 year duration
and .10 year duration in the highest SUA quartile was 0.615,
0.505, and 0.341, respectively). Finally, multivariate logistic

Data collection
In the 2007–8 China National Diabetes and Metabolic
Disorders Study, a physical examination was performed on all
subjects by a qualified doctor per established standard methods
[15]. This physical examination documented measurements of
height, weight, waist circumference (defined as smallest circumference between the rib margin and iliac crest), hip circumference
(defined as maximum circumference between the waist and hips).
The accuracy of all above parameters is defined as 0.5 cm. Body
mass index (BMI) was calculated by dividing body weight (kg) by
the square of height (m2). Maximum BMI was calculated by
dividing maximum body weight (kg) by the square of height (m2).
Waist-to-hip ratio (WHR) was calculated as waist circumference
divided by hip circumference. Data collection was performed at
local health stations or community clinics. A standardized
questionnaire was completed by trained physicians and nurses.
Data collected from each subject included lifestyle, self-reported
maximum weight, medication usage and educational level.
Smoking was defined as smoking one or more cigarettes daily
for at least one year. Alcohol use was defined as consumption of at
least 30 grams of alcohol per week for 1 year or more. Regular
leisure-time physical activity was defined as participation in
moderate or vigorous activity for 30 minutes or more daily at
least 3 days per week. Maximum weight was defined as, heretofore
presently, the maximum weight the subject has attained, as selfreported. Duration of maximum weight was defined as, to the
survey date, the subject self-reported time that maximum weight
kept stable. Time interval between maximum and current weight
was defined as time from the end of self-reported maximum weight
(essentially time of weight loss took place) to the survey date.
Absolute weight loss was defined as the difference between
maximum weight and current weight. If the maximum weight was
the current weight, the difference would be zero. Hyperuricemia
was defined as SUA concentration.7.0 mg/dl (420 mmol/l,

PLOS ONE | www.plosone.org

2

November 2012 | Volume 7 | Issue 11 | e51186

Association of Maximum Weight with SUA Risk

Table 1. Study Cohort Characteristics per SUA Quartile.

Characteristics

Male quartile of Uric Acid Concentrationa(N = 8630)
1(,265mmol/L)

2(265mmol/L-317mmol/L)

3(317mmol/L-374mmol/L)

4(.374mmol/L)

No. of subjects

2160

2146

2190

2134

Mean uric acid (95% CI), mmol/L

221.47(219.91–223.03)

292.19(291.55–292.82)

344.68(343.99–345.37)

436.52(434.03–439.02)
86.48(85.24–87.71)

Mean creatinine (95% CI), mmol/L

81.80(80.64–82.96)

83.24(81.05–85.42)

83.02(81.77–84.28)

Mean age (95% CI)b, y

45.78(45.18–46.39)

44.92(44.32–45.53)

44.92(44.33–45.51)

44.98(44.38–45.58)

Smoking (95% CI)c, %

49.16(48.02–52.24)

52.33(50.22–54.44)

53.34(50.41–54.65)

54.53(52.25–56.43)

Drinking (95% CI)d,%

37.87(35.81–39.90)

46.32(44.21–48.43)

49.45(47.36–51.55)

55.25(53.14–57.36)

Mean current weight(95% CI), Kg

64.46(64.02–64.88)

67.27(66.80–67.73)

69.43(68.96–69.89)

73.68(73.16–74.20)

Mean BMI (95% CI), kg/m2

23.02(22.88–23.15)

23.86(23.70–24.01)

24.46(24.31–24.61)

25.78(25.62–25.94)

Mean WC (95% CI), cm

82.17((81.76–82.58)

83.91(83.48–84.34)

85.65(85.22–86.07)

89.32(88.88–89.76)

Mean WHR (95% CI)

0.87(0.86–0.87)

0.88(0.87–0.88)

0.89(0.88–0.89)

0.91(0.90–0.91)

Mean maximum weight (95% CI), Kg

69.13(68.66–69.61)

71.75(71.22–72.27)

73.26(72.75–73.77)

77.26(76.73–77.79)

Mean age at maximum weight (95% CI), y

35.32(34.73–35.91)

36.84(36.25–37.42)

37.20(36.61–37.79)

38.54(37.95–39.12)

Mean maximum BMI (95% CI), kg/m2

24.70(24.55–24.85)

25.46(25.28–25.63)

25.81(25.65–25.98)

27.04(26.87–27.19)

Mean Dweight (95% CI), Kg

4.68(4.41–4.94)

4.48(4.18–4.78)

3.83(3.57–4.09)

3.58(3.38–3.78)

a

Female quartile of Uric Acid Concentration (N = 12784)
1(,199mmol/L)

2(199mmol/L-238mmol/L)

3(238mmol/L-282mmol/L)

4(.282mmol/L)

No. of subjects

3232

3239

3111

3202

Mean uric acid (95% CI), mmol/L

166.68(165.70–167.65)

219.35(218.95–219.74)

259.17(258.73–259.61)

333.51(331.62–335.40)

Mean creatinine (95% CI), mmol/L

65.60(64.96–66.23)

65.73(65.11–66.35)

68.53(64.10–72.95)

70.58(69.07–72.10)

Mean age (95% CI), y

42.33(41.91–42.75)

43.34(42.89–43.79)

45.32(44.86–45.79)

48.64(48.15–49.13)

Smoking (95% CI)bc, %

2.51(1.97–3.05)

2.41(1.88–2.94)

2.96(2.36–3.55)

3.34(2.72–3.96)

Drinking (95% CI)bd, %

3.84(3.17–4.50)

4.38(3.68–5.09)

4.50(3.77–5.23)

5.18(4.42–5.95)

Mean current weight (95% CI), Kg

56.20(55.91–56.49)

57.45(57.15–57.76)

59.34(59.00–59.68)

61.60(61.23–61.96)

Mean BMI (95% CI), kg/m2

22.76(22.65–22.87)

23.25(23.13–23.36)

24.02(23.89–24.15)

24.95(24.81–25.09)

Mean WC (95% CI), cm

76.66(76.33–76.97)

77.68(77.34–78.01)

79.64(79.28–80.00)

82.37(81.99–82.74)

Mean WHR (95% CI)

0.82(0.81–0.83)

0.83(0.82–0.83)

0.84(0.83–0.84)

0.86(0.85–0.86)

Mean maximum weight (95% CI), Kg

60.44(60.11–60.76)

61.63(61.29–61.97)

63.33(62.96–63.69)

65.30(64.93–65.68)

Mean age at maximum weight (95% CI), y

33.55(33.11–33.99)

34.93(34.46–35.39)

37.27(36.77–37.76)

39.83(39.3–40.36)

Mean maximum BMI (95% CI), kg/m2

24.48(24.35–24.61)

24.94(24.81–25.07)

25.63(25.49–25.77)

26.45(26.20–26.59)

Mean Dweight (95% CI), Kg

4.24(4.04–4.43)

4.17(3.96–4.38)

3.98(3.77–4.20)

3.69(3.51–3.88)

Continuous data are presented as mean, Categorical data are presented as percentage. To convert uric acid level from mmol/L per liter to mg/dL, values were divided by
59.48. BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio; Dweight: difference between current and maximum weight. Maximum weight could be
the current weight.
a
: All P values ,0.001.
b
: P values .0.05.
c
: Smoking was defined as having smoked at least 100 cigarettes in one’s lifetime.
d
: Drinking was defined as consumption of at least 30 g of alcohol per week for 1 year or more.
doi:10.1371/journal.pone.0051186.t001

regression models demonstrated significant risk reduction for
elevated SUA as maximum weight loss increased (Table 5). When
absolute maximum weight loss exceeded 5 kilograms, the OR in
the second, third, and fourth quartile was 0.682, 0.522, and 0.407,
in comparison to the lowest SUA quartile.
Receiver operating characteristic (ROC) curve analysis demonstrated statistically significant value of maximum weight for
hyperuricemia diagnosis (area under the curve was 0.661 with
95% CI of 0.647–0.674, P,0.001). The sensitivity and specificity
for a maximum weight value 70 kilograms in diagnosing
hyperuricemia was 53.5% and 70.4%, respectively (Figure 1).

PLOS ONE | www.plosone.org

Discussion
In this retrospective study, we have demonstrated the relationship between the risk of high SUA level and maximum weight in
the Chinese population. Especially in the group of subjects with
high SUA level, their maximum weight and maximum BMI were
usually high. After adjustment for related confounding factors,
multivariate logistic regression models revealed an association
between maximum weight and increased risk of SUA elevation.
Weight stability, time of weight loss, the degree of weight loss, and
weight loss itself were inversely related with risk of SUA elevation.
Finally, ROC curve analysis demonstrated a statistically significant
diagnostic value of maximum weight for hyperuricemia diagnosis.
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the height to some extent. Strictly speaking, for maximum BMI,
height can be used only at the time when subjects’ weights reach
the maximum value. In our survey, the percentage of the seniors is
16.18% of the over all participants. For these individuals, it is too
difficult to recall the exact height when the weight was at the
highest values in lifetime. And in fact the BMI values change as a
result of shrink in height with the aging process [21,22]. In
addition, we also found that for correlation coefficient, maximum
BMI or maximum weight were 0.177 and 0.194 respectively. The
area under the ROC curve of maximum BMI and maximum
weight was 0.637 (data not shown) and 0.661 sequentially. These
data indicated that maximum weight is slightly superior to
maximum BMI in our study.
Next, we further analyzed sub-parameters including time of
weight loss and the degree of weight loss from the maximum
weight. In this study, we found that weight loss from maximum
weight is more significant to decrease the risk for SUA elevation.
Previous published paper indicated that weight loss was thought to
be an effective non medical strategy for SUA level reduction in the
Japanese population [8]. Men losing 10 pounds or more had a
39% lower risk of developing gout [23]. But it is still necessary to
observe the effects of weight loss, especially from maximum weight
on SUA levels with large-scale study in Chinese population. Our
data suggested that the risk of high SUA level became lower with
weight loss increasing. Moderate weight loss (,5 Kg)lower the risk
of SUA elevation up to 45%. Over 5 Kg weight loss will further
reduce the risk by 60% at least (Table 5). So we think that more
pounds you lose, more benefits to reduce risk of hyperuricemia you
get, especially for individuals who lose weight over 5 kilograms
from maximum weight.
Furthermore, the time of weight loss starting was thought to be
another important factor. Ezequiel DG et al. reported weight

Table 2. Multiple Logistic Regression Analyses of SUA
quartiles Association with Maximum Weight.

Uric Acid
Quartile

Maximum Weight (OR 95%CI)
,60Kg

60–70Kg

.70Kg

Quartile 1

1.000

1.000

1.000

Quartile 2

1.000

1.109(0.976–1.261)

1.275(1.076–1.509)

Quartile 3

1.000

1.447(1.263–1.657)

2.233(1.882–2.648)

Quartile 4

1.000

1.664(1.423–1.944)

3.513(2.916–4.232)

This model was adjusted for age, sex, height, smoking, drinking, education,
physical activity, waist-hip ratio, eGFR, and diuretic use. CI, Confidence interval;
OR, odds ratio; eGFR, evaluate glomerular filtration rate.
doi:10.1371/journal.pone.0051186.t002

Although several studies have previously demonstrated association between SUA and body weight [19,20], the relationship
between maximum individual body weight and the risk of
hyperuricemia was unknown. To our knowledge, the present
study is the first reporting the association of maximum weight with
increased risk of elevated SUA level. Maximum weight is thought
to be a more valuable prediction marker for the risk of elevated
SUA level. For the clinical doctors, maximum weight is more
attractive for it is easy to get it. So doctors are easier to predict the
individuals’ risk of high SUA. Especially for those individuals
whose maximum weight are over 70 kg, doctors need remind
them to be followed up (Table 2, Figure 1).
Previous studies often chose maximum BMI as an indicator for
high SUA level. Here we used maximum weight not BMI. We
think maximum weight can minimize the potential deviation from

Table 3. Multiple Logistic Regression Analyses of SUA Quartiles Association with Duration of Maximum Weight.

Uric Acid Quartile

Duration of Maximum Weight (OR 95%CI)
1–2 year

.3 year

0year

0–1 year

2–3 year

Quartile 1

1.000

1.000

1.000

1.000

1.000

Quartile 2

1.000

0.783 (0.650–0.942)

0.754 (0.638–0.891)

0.634 (0.510–0.787)

0.619 (0.518–0.739)

Quartile 3

1.000

0.673 (0.568–0.799)

0.579 (0.477–0.702)

0.537 (0.448–0.643)

0.498 (0.398–0.623)

Quartile 4

1.000

0.577 (0.481–0.693)

0.509 (0.414–0.626)

0.423 (0.349–0.513)

0.410 (0.323–0.521)

This model was adjusted for age, sex, height, smoking, drinking, education, physical activity, waist-hip ratio, eGFR, and diuretic use. CI, Confidence interval; OR, odds
ratio. eGFR, evaluate glomerular filtration rate.
doi:10.1371/journal.pone.0051186.t003

Table 4. Multiple Logistic Regression Analyses of SUA Quartiles Association with Time Interval between the end of Maximum and
Current Weight.

Uric Acid Quartile

Time interval between the end of maximum and current weight (OR 95%CI)
0 year

0–5 year

5–10 year

.10 year

Quartile 1

1.000

1.000

1.000

1.000

Quartile 2

1.000

0.855 (0.730–1.000)

0.668 (0.543–0.821)

0.596 (0.493–0.721)

Quartile 3

1.000

0.686 (0.583–0.807)

0.562 (0.453–0.696)

0.384 (0.313–0.470)

Quartile 4

1.000

0.615 (0.516–0.733)

0.505 (0.398–0.639)

0.341 (0.274–0.426)

This model was adjusted for age, sex, height, smoking, drinking, education, physical activity, waist-hip ratio, eGFR, and diuretic use. CI, Confidence interval; OR, odds
ratio. eGFR, evaluate glomerular filtration rate.
doi:10.1371/journal.pone.0051186.t004
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Table 5. Multiple Logistic Regression Analyses of SUA
Quartiles Association with Absolute Weight Loss.

Uric Acid
Quartile

Degree of Weight Loss (OR 95%CI)
0Kg

0–2Kg

2–5Kg

.5Kg

Quartile 1

1.000

1.000

1.000

1.000

Quartile 2

1.000

0.837
(0.715–0.979)

0.692
(0.597–0.802)

0.682
(0.587–0.791)

Quartile 3

1.000

0.702
(0.597–0.824)

0.592
(0.509–0.688)

0.522
(0.448–0.609)

Quartile 4

1.000

0.738
(0.621–0.876)

0.554
(0.471–0.652)

0.407
(0.344–0.481)

This model was adjusted for age, sex, height, smoking, drinking, education,
physical activity, waist-hip ratio, eGFR, and diuretic use. CI, Confidence interval;
OR, odds ratio. eGFR, evaluate glomerular filtration rate.
doi:10.1371/journal.pone.0051186.t005

reduction group showed a trend toward a reduction of SUA after a
12-week calorie-restricted diet [24]. Another study that observation of obese who treatment with sibutramine for 1 year showed
serum uric acid was lowered significantly with weight loss [25]. But
it is still not clear how the time of weight loss starting, or time
interval from the end of self-reported maximum weight to the
survey date influents SUA elevation. We have strong evidence that
the longer interval, the lower risk of SUA level elevation (Table 4).
That means individuals need lose weight as early as possible from
the maximum weight. That definitely will bring more benefits to
lower risk of hyperuricemia and its consequences.
During the process of analyzing data, we found in all of loosing
weight subjects, the percentage was 43% whose weight went down
to their standard weight from maximum weight. The rest subjects
show weight loss with different degrees. For some reasons such as
psychological factors and living habits, it is too difficult for them to
lose weight continuously. So at this time, keeping weight stability
or rapid weight fluctuation, which one is better for decreasing their
risk of high SUA level? As we all known, weight fluctuation (lossgain or gain-loss) can alter various metabolic factors such as blood
pressure, blood sugar, SUA, high-density-lipoprotein-cholesterol
and obesity [26]. When subjects experience weight fluctuations,
SUA level will be changed as a result, although rapid weight loss
would elevate uric acid level temporarily [27]. The ERFORT
Male Cohort Study also indicated that weight fluctuations are a
major risk factor for all-cause mortality. Stable weight does not
increase further mortality even if they are obese [28]. On this
point, we got the similar results. Our study demonstrated
maintaining weight stability will be beneficial for risk of high
SUA reduction (Table 3). Of course, loosing weight firstly appears
to have more positive effects upon reduce risk of uric acid
elevation. So based on above mentioned, we propose that
individuals should attempt to maintain a stable weight especially
for them whose weights are too difficult to keep loosing
continuously, no matter their weights go down to standard range.
The Framingham Heart Study established the dangerous
relationship between SUA level elevation and coronary heart
disease occurrence, cardiovascular death, and all-cause mortality
in females [7]. An eight years follow-up study upon 128,569 adults
conducted by Pan in Taiwan, China, concluded the hyperuricemia was independently associated with the development of
ischemic heart disease not only in the general population but also
in those without any metabolic risk factor [29]. The extension of
our study’s results demonstrating weight stability with decreased
PLOS ONE | www.plosone.org

Figure 1. ROC curve demonstrating diagnostic value of
maximum weight forhyperuricemia. Receiver operating characteristic (ROC) curve analysis demonstrated statistically significant value of
maximum weight for hyperuricemia diagnosis (area under the curve
was 0.661 with 95% CI of 0.647–0.674, P,0.001).
doi:10.1371/journal.pone.0051186.g001

risk of SUA level elevation to actual decreased risk of cardio/
cerebrovascular events is under current investigation.
Our study has several limitations. Firstly, we have no
information regarding the extent to which lifestyle and dietary
habit modifications affect our study population. Secondly,
information regarding body maximum weight was self-reported,
whereas current weight and height were directly measured by
trained staff. Previous studies, however, have validated selfreported past body weight, demonstrating great accuracy in
comparison to measured body weight [30,31]. Thirdly, our study’s
data set was a part of the 2007–8 China National Diabetes and
Metabolic Disorders Study, which did not assess the prevalence of
hyperuricemia in China. Finally, as our study was observational,
we cannot rule out the possibility unmeasured factors may
contribute to observed associations.

Conclusion
Our large retrospective study indicates that maximum weight is
a strong risk factor for hyperuricemia in the Chinese population.
Weight stability, time of weight loss, the degree of weight loss, and
weight loss itself was inversely proportional to the risk of elevated
uric acid level. Controlling maximum weight, keeping weight to
the appropriate range, and maintaining the stable weight may be
conducive for decreasing risk of hyperuricemia. Maximum weight
is an easy and accurate indicator to value the increased SUA level,
which may potentially serve as a novel clinical indicator for
identifying patients at high risk of hyperuricemia.
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